Abstract

The nanotechnology is prominent in medicine for various applications. Nanotechnology is a multidisciplinary field, which covers diverse arrays of devices made using principles of engineering, biology, physics, and chemistry. The increasing number of nanomedicines is approved clinically, used safely, which highlights the important role of nanotechnology in the field of cancer research. The successful application of nanotechnology to the targeted smart drug therapy ISA rapidly growing component of armamentarium against cancer. Nanotechnology is being applied to cancer in two broad areas: the development of nanovectors, such as nanoparticles, which can be loaded with drugs or imaging agents and then targeted to tumors, and high throughput nanosensor devices for detecting the biological signatures of cancer. This advanced technology provides a unique approach and comprehensive technology against cancer through early diagnosis, prediction, prevention, personalized therapy, and medicine. This review focuses on nanotechnology-based clinical approaches in the advancements of cancer therapy.

Highlights

  • Cancer is a leading cause of death worldwide

  • About 595,690 Americans are expected to die of cancer in 2016, which translates to about 1,630 people per day

  • In the last decade, two emerging hallmarks are reprogramming of energy metabolism and evading immune destruction (Figure 1)

Read more

Summary

DGandhali A Deshpande*

The nanotechnology is prominent in medicine for various applications. Nanotechnology is a multidisciplinary field, which covers diverse arrays of devices made using principles of engineering, biology, physics, and chemistry. The successful application of nanotechnology to the targeted smart drug therapy ISA rapidly growing component of armamentarium against cancer. Nanotechnology is being applied to cancer in two broad areas: the development of nanovectors, such as nanoparticles, which can be loaded with drugs or imaging agents and targeted to tumors, and high throughput nanosensor devices for detecting the biological signatures of cancer. This advanced technology provides a unique approach and comprehensive technology against cancer through early diagnosis, prediction, prevention, personalized therapy, and medicine.

Introduction
Low systemic toxicity Batter and faster responses
Drug targeting strategies
Choice of targeting ligand
Choice of target receptor
Discussion and Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.